Monique Roobol

Monique Roobol is a Full Professor in the Department of Urology at Erasmus MC, a leading academic medical center in the Netherlands. She is a key figure in prostate cancer research, particularly in the areas of screening, early detection, and risk stratification. Her work bridges clinical urology and public health policy, with significant contributions to European screening programs and clinical guidelines.

Her research interests focus on prostate cancer screening, MRI-based diagnostics, biopsy techniques, and reducing overtreatment in prostate cancer. She actively investigates the role of prostate-specific antigen (PSA) testing, multiparametric MRI (mpMRI), and risk classification systems to improve patient outcomes and healthcare efficiency.

The recent articles highlight a strong trend toward evidence-based policy making and optimizing diagnostic pathways in prostate cancer. Her work integrates large-scale clinical data, health systems analysis, and guideline development, with a focus on MRI capacity, guideline appraisal (e.g., AGREE-II), and long-term outcomes from randomized trials like ERSPC. These studies reflect a multidisciplinary approach combining radiology, urology, epidemiology, and public health.

Monique Roobol has supervised 14 research projects, indicating her active role in mentoring junior researchers and contributing to academic training in urologic oncology. She is involved in major collaborative networks such as the ERSPC Rotterdam Study Group and the OPTIMA consortium, which support her extensive research and policy engagement. Although no specific grants are listed, her leadership in multi-institutional studies suggests significant grant funding and project coordination.

She is affiliated with the following research groups and initiatives:

• ERSPC Rotterdam Study Group
• OPTIMA consortium
• European Association of Urology (EAU) and Young Academic Urologists (YAU)
• European Urology Oncology and European Journal of Radiology research collaborations